These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446 [TBL] [Abstract][Full Text] [Related]
3. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018 [TBL] [Abstract][Full Text] [Related]
4. Thyroid carcinoma in childhood: management and follow up of 11 cases. Jocham A; Joppich I; Hecker W; Knorr D; Schwarz HP Eur J Pediatr; 1994 Jan; 153(1):17-22. PubMed ID: 8313918 [TBL] [Abstract][Full Text] [Related]
5. Papillary and follicular thyroid carcinoma. Schlumberger MJ; Torlantano M Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737 [TBL] [Abstract][Full Text] [Related]
6. [Draft of the best medical treatment in patients with low-risk thyroid cancer]. Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of differentiated carcinoma of the thyroid gland]. Mimura T; Ito K Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097 [No Abstract] [Full Text] [Related]
8. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution. Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082 [TBL] [Abstract][Full Text] [Related]
9. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506 [TBL] [Abstract][Full Text] [Related]
10. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression. Khan M; Syed AA; Khan AI; Hussain SR; Urooj N Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398 [TBL] [Abstract][Full Text] [Related]
11. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis. Muller S; Senne M; Kirschniak A; Königsrainer A; Bares R; Falch C World J Surg Oncol; 2017 Oct; 15(1):190. PubMed ID: 29065879 [TBL] [Abstract][Full Text] [Related]
12. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Mazzaferri EL; Jhiang SM Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430 [TBL] [Abstract][Full Text] [Related]
15. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation. Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013 [TBL] [Abstract][Full Text] [Related]
16. [Familial nonmedullary thyroid cancer]. Sugino K; Mimura T; Ito K; Ito K Nihon Rinsho; 2000 Jul; 58(7):1519-22. PubMed ID: 10921335 [TBL] [Abstract][Full Text] [Related]